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1943–2011121Science is driven by creative individuals who are given room and scope to
develop new ways of thinking, new methods, and new ways of approaching
problems and who take risks to create new knowledge.—Torsten N. Wiesel,
President Emeritus, The Rockefeller University.Ralph M. Steinman, professor of immu-
nology at The Rockefeller University in
New York and one of the great immunolo-
gists of our time, died on September 30
after a long fight with pancreatic cancer,
just three days before the announcement
that he had been awarded the Nobel
Prize in Physiology or Medicine for the
discovery of the dendritic cell. Steinman
is universally recognized for having given
birth to the vibrant field of dendritic cell
biology and for having nurtured it through
many years of skepticism and dispute to
its current position as a central paradigm
of modern immunology.
Born in a family of Jewish immigrants
from Eastern Europe in Sherbrooke,
Quebec, Ralph Steinman received his
undergraduate degree from McGill
University in 1963 and his medical
degree from Harvard Medical School inRalph M. Steinman1968. He completed internship and
residency training at the Massachu-
setts General Hospital in Boston
before joining, in 1970, the labora-
tory of Zanvil Cohn and James
Hirsch at The Rockefeller University,
where he spent his entire scientific
career.
The work of Ralph Steinman is
a remarkable example of research
focused on the understanding of
the cellular basis of the immune
response. In the early 1970s, it was
known that an accessory cell was
required for induction of adaptive
immunity, but the nature of this
cell was the subject of intense
debate. Most researchers in the
field thought that it was a macro-
phage, given that the cell was
known to be of hematopoietic origin,
present in spleen, and adherent
to glass and was known to express
MHC class II molecules. Because
his studies with Cohn did not6 Cell 147, December 9, 2011 ª2011 Elsesupport a role for macrophages, Stein-
man set out to dissect the cellular compo-
nents of the lymphoid tissues, where it
was known that adaptive immunity
develops after infection or vaccination.
Careful microscopic analysis allowed
Steinman to recognize in these tissues a
new cell type with distinctive morphology
that led him to denote it as ‘‘dendritic
cell.’’ In a seminal paper published in the
Journal of Experimental Medicine in
1973, Steinman showed that these cells
were clearly different than the macro-
phages, according to a variety of criteria:
they were motile, constantly extending
and retracting many fine cell processes;
had low endocytic and proteolytic activity;
and expressed MHC class II molecules.
Steinman developed methods to enrich
or deplete mouse dendritic cells from
spleen and lymph nodes that werevier Inc.instrumental for performing functional
experiments.
In 1978, Steinman and Witmer showed
that dendritic cells were the most potent
cells capable of eliciting the mixed
lymphocyte reaction (an in vitro correlate
of a primary T cell response), being at
least 100-fold more potent than unfractio-
nated splenic cells. Steinman was the first
to show a differential requirement for
activation of naive versus primed T cells
and to realize the implications of this
finding, which was not appreciated by
his contemporaries. In the 1978 paper,
Steinman hypothesized that naive T
lymphocytes ‘‘may have to recognize
something that exists in or on dendritic
cells in addition to the MHC antigens,’’
a prediction that remarkably anticipated
the discovery of T cell costimulation.
Steinman and coworkers were also able
to discriminate the requirements for naive
T cell activation from the requirements for
delivery of T cell help to B cells. These
studies established the central role of
the dendritic cell in all of the adaptive
immune responses, whether mediated
by CD4 or CD8 T cells or through interac-
tion of CD4 T cells with B cells.
In 1985, Steinman and Schuler reported
that Langerhans cells present in the
skin represent a special type of imma-
ture dendritic cells that spontaneously‘‘mature’’ in vitro by acquiring T cell
stimulatory capacity comparable to
that of splenic dendritic cells. In
this study, Steinman proposed that
‘‘functioning lymphoid dendritic
cells may in general be derived
from lessmature precursors located
in nonlymphoid tissues,’’ thus intro-
ducing the concept of dendritic cell
maturation as a unifying working
principle of dendritic cell biology.
According to the proposed model,
dendritic cells reside in peripheral
tissues or are recruited there in an
immunologically immature state
characterized by high endocytic
activity and poor T cell stimulatory
capacity. In response to yet not
identified stimuli, these cells were
proposed to undergo a complex
maturation process leading to loss
of endocytic activity, acquisition of
T cell stimulatory capacity, and
migration to the draining lymph no-
des. This model finally merged
Langerhans cells and other cell types,
such as ‘‘veiled’’ cells present in afferent
lymph and ‘‘passenger leukocytes’’
responsible for induction of graft rejec-
tion, into a coherent picture in which
immature dendritic cells act as sentinels
in peripheral tissues and mature dendritic
cells act as initiators of the immune
response in lymphoid tissues.
A few years after Steinman’s discovery
of dendritic cell maturation, Charles Jane-
way Jr. proposed, in a visionary article
published in 1989, that the initiation
of the adaptive immune response would
be controlled by innate receptors specific
for pathogen-associated molecular pat-
terns, a proposal that was followed by
the discovery by Jules Hoffmann and
Bruce Beutler of the role of Toll-like recep-
tors (TLRs) in pathogen recognition and in
triggering innate immunity. TLRs, as well
as other innate receptors, are expressed
in many cell types, but it is their expres-
sion in dendritic cells and their capacity
to elicit dendritic cell maturation and cyto-
kine production that bridge innate and
adaptive immunity.
In the early 1990s, the dendritic cell field
became experimentally more approach-
able due to the development of culture
methods, including those pioneered by
Steinman together with Kayo Inaba, to
obtain large numbers of dendritic cells
starting from bone marrow precursors or
from peripheral blood monocytes. The
field attracted a number of researchers
that became interested in understanding
the cell biology of dendritic cell maturationand in identifying the stimuli and recep-
tors that trigger the maturation process.
Throughout the 1990s numerous studies
dissected the mechanisms of antigen
uptake, processing, and presentation;
identified microbial products and inflam-
matory cytokines as maturation-inducing
stimuli; and shed light on the regulated
expression of costimulatory molecules
and polarizing cytokines in maturing
dendritic cells. Other studies revealed
the heterogeneity and plasticity of
dendritic cell populations and identified
subsets specialized in priming CD4
versus CD8 T cells. Thus, after more
than 20 years from the discovery, in
which dendritic cell research was nearly
confined in the Steinman laboratory, the
field exploded into the hottest area of
immunological research, with Steinman
remaining the leading and guiding figure.
In line with his medical education,
Steinman pioneered studies on the inter-
action of dendritic cells with human
pathogens and showed a profound
interest for the clinical application of
dendritic cells as vaccines to enhance
the immune responses against infectious
agents and cancer or to suppress them
to reduce or prevent autoimmune
diseases. Steinman realized the limita-
tions of a therapeutic approach based
on in vitro-cultured dendritic cells and,
together with his former student Michel
Nussenzweig, designed a strategy to
target dendritic cells in vivo. This ap-
proach led to the unexpected finding
that antigens targeted in vivo to immatureCell 147, Ddendritic cells induce T cell tolerance,
which is turned into a potent immune
response if the dendritic cells also receive
a maturation stimulus. These studies not
only indicated a new pathway toward
more effective vaccines, but also demon-
strated the central role of dendritic cells
in peripheral T cell tolerance, a finding
that has important implications for under-
standing autoimmunity.
Steinman’s discovery of dendritic cells
as initiators and regulators of immunity
represent one of the most significant
advances in immunology, the importance
of which continues to grow even today.
His seminal contributions have been
recognized by many awards, including
the prestigious Gairdner and Lasker
Awards in 2003 and 2007 and the Nobel
Prize in 2011. Throughout his entire career,
Steinman showed a total dedication to
science, being an inspiring mentor for
young scientists and a wonderful and
generous colleague. He was also a
passionate advocate for the integration of
basic knowledge on dendritic cell biology
into the development of new vaccines
and treatments. Thesewords best capture
his contagious enthusiasm and commit-
ment: ‘‘Vaccine science, while exciting
and important, is also really demanding.
So let’s help each other and share inter-
ests, findings, resources, concerns that
are pertinent to this ‘field of the future,’ in
which vaccines will be comprised of
defined antigens and adjuvants, appro-
priate to the many medical conditions
that involve the immune system.’’Antonio Lanzavecchia1,*
and Federica Sallusto1,*
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CH-6500 Bellinzona, Switzerland
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